Search

Search Constraints

You searched for: Author/Creator Rea, D.

Search Results

1. Cardiotoxicity and pro-inflammatory effects of the immune checkpoint inhibitor Pembrolizumab associated to Trastuzumab. (1st October 2019)

3. Optimising the Duration of Adjuvant Trastuzumab in Early Breast Cancer in the UK. Issue 1 (January 2021)

4. 1809 Results of the OPTIMA (Optimal Personalized Treatment of early breast cancer usIng Multi-parameter Analysis) prelim study. (September 2015)

5. P707: DOSE MODIFICATION DYNAMICS OF PONATINIB IN PATIENTS WITH CHRONIC-PHASE CHRONIC MYELOID LEUKEMIA (CP-CML) FROM THE PACE AND OPTIC TRIALS. (23rd June 2022)

6. P700: TREATMENT-FREE REMISSION (TFR) AFTER DASATINIB IN PATIENTS WITH CHRONIC MYELOID LEUKEMIA IN CHRONIC PHASE (CML-CP) AND DEEP MOLECULAR RESPONSE (DMR): FINAL 5-YEAR RESULTS OF DASFREE. (23rd June 2022)

7. S155: EFFICACY AND SAFETY RESULTS FROM ASCEMBL, A PHASE 3 STUDY OF ASCIMINIB VS BOSUTINIB IN PATIENTS WITH CHRONIC MYELOID LEUKEMIA IN CHRONIC PHASE AFTER ≥2 PRIOR TYROSINE KINASE INHIBITORS: WK 96 UPDATE. (23rd June 2022)

8. Strategies to Improve Recruitment to a De-escalation Trial: A Mixed-Methods Study of the OPTIMA Prelim Trial in Early Breast Cancer. Issue 6 (June 2020)

9. The Distribution of PSA Age-Specific Profiles in Healthy Irish Men between 20 and 70. (8th July 2012)

10. The presentation, management and outcome of inflammatory breast cancer cases in the UK: Data from a multi-centre retrospective review. (December 2018)